Work has been completed on a new dual-site facility in Nottingham which will produce the next generation of medical devices and technologies.
Nottingham Trent University’s £23 million Medical Technologies Innovation Facility (MTIF) will bring organisations and clinicians together with university researchers to develop their ideas and get them to market as quickly as possible.
The project was supported by £9.7m from the D2N2 Local Enterprise Partnership, through its Local Growth Fund allocation.
The MTIF project is expected to improve the lives of patients, reduce the cost of care and stimulate the regional economy. It will focus on supporting the development of innovative products and advanced materials to meet a range of future healthcare needs and accelerate innovation.
Work now been completed at the university’s Clifton Campus and at the Boots site on the Nottingham Enterprise Zone.
The site on the Clifton Campus will focus on research and development, linking academics with industry to provide a multidisciplinary approach to medical technology development.
The Boots site, meanwhile, will be dedicated to the development, clinical production and commercialisation of new medical technologies. This site will provide access to laboratories, clean rooms, technologies and expertise for processing, prototype development and preparing manufacturing processes.
Major innovation asset
MTIF is expected to become a major specialist innovation asset within the Midlands Engine, supporting industry and enhancing the regional economy in the areas of life sciences and healthcare.
Nottingham Trent University Vice-Chancellor, Professor Edward Peck, said: “This development is a major part of the investment that NTU is making in ensuring the future sustainability and growth of the economy of the City, County and Region.”
Sajeeda Rose, Chief Executive of the D2N2 Local Enterprise Partnership, said: “D2N2 is proud to have invested over £9.7m from the Local Growth Fund into the dual-site Medical Technologies Innovation Facility (MTIF) on NTU’s Clifton Campus and the Boots site, which is part of the Nottingham Enterprise Zone.
“Life sciences and healthcare is a key sector for the D2N2 LEP, not only helping patients get better treatment but also playing a dynamic role in driving forward the economic growth of the region.”
MTIF Managing Director, Mike Hannay, said: “This is hugely exciting development for Nottingham and the wider region. MTIF will bring companies, clinicians and university researchers together to take their ideas from bench to bedside, accelerating the speed of innovation to improve patient care.”
Henry Brothers and GF Tomlinson have been the main contractors for the Clifton Campus and Boots site, respectively.
Keep up to date with all the latest news from D2N2 by signing up to our Newsletter.
